LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer.

about

No convincing evidence on differences in metabolic effects of medical and surgical castration in the treatment of prostate cancer.Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer-time for a rethink?

P2860

Q48194331-36949CFE-3CDE-4489-B787-5A84A30A9B4A Q52647565-8C230FAD-2770-48FA-A503-DA424C01E8A8

P2860

LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer.

Item

http://www.wikidata.org/entity/Q39831515

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

LHRH analog therapy is associa ...... rchiectomy in prostate cancer.

@en

LHRH analog therapy is associa ...... rchiectomy in prostate cancer.

@nl

type

Item

label

LHRH analog therapy is associa ...... rchiectomy in prostate cancer.

@en

LHRH analog therapy is associa ...... rchiectomy in prostate cancer.

@nl

prefLabel

LHRH analog therapy is associa ...... rchiectomy in prostate cancer.

@en

LHRH analog therapy is associa ...... rchiectomy in prostate cancer.

@nl

P1476

LHRH analog therapy is associa ...... rchiectomy in prostate cancer.

@en

P2093

Andreza Vargas

http://www.w3.org/2001/XMLSchema#string

Carlos Eduardo Paiva

http://www.w3.org/2001/XMLSchema#string

Daniel Ianni Filho

http://www.w3.org/2001/XMLSchema#string

Eliney Ferreira Faria

http://www.w3.org/2001/XMLSchema#string

Marcos Tobias-Machado

http://www.w3.org/2001/XMLSchema#string

Roberto Dias Machado

http://www.w3.org/2001/XMLSchema#string

Rodolfo Borges Dos Reis

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer.

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.

Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.

Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.

Androgens and erythropoiesis: past and present.

DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet.

Body composition alterations, energy expenditure and fat oxidation in elderly males suffering from prostate cancer, pre and post orchiectomy.

Effects of radiation and total androgen blockade on serum hemoglobin, testosterone, and erythropoietin in patients with localized prostate cancer.

Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis.

P2888

s00345-016-1831-5

P304

1621-1628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00345-016-1831-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27103427

http://www.w3.org/2001/XMLSchema#string

LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer.

about

P2860

P2860

LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698